TRIP6 is a RIP2-associated common signaling component of multiple NF-κB activation pathways

• DOI: 10.1242/jcs.01641
• Publication Date: 2005-01-19T02:57:50Z
• Authors: Lianyun Li; Liang-Hua Bin; Fu Li; Yi Liu; Danying Chen; Zhonghe Zhai; Hong-Bing Shu
• Keywords: 0301 basic medicine; Proteasome Endopeptidase Complex; Binding Sites; Membrane Glycoproteins; NF-kappa B; Gene Expression; Proteins; LIM Domain Proteins; Protein Serine-Threonine Kinases; Cell Line; 3. Good health; DNA-Binding Proteins; 03 medical and health sciences; Receptor-Interacting Protein Serine-Threonine Kinase 2; Nod1 Signaling Adaptor Protein; Proto-Oncogene Proteins; Receptor-Interacting Protein Serine-Threonine Kinases; ATPases Associated with Diverse Cellular Activities; Humans; Extracellular Signal-Regulated MAP Kinases; Adaptor Proteins, Signal Transducing; Interleukin-1; Protein Binding

Receptor-interacting protein 2 (RIP2) is a member of the RIP kinase family that has been shown to be crucially involved in inflammation, innate and adaptive immune responses. The physiological and pathological roles of RIP2 are mediated through its involvement in multiple NF-κB activation pathways, including those triggered by tumor necrosis factor (TNF), interleukin 1 (IL-1), Toll-like receptor 2 (TLR2), TLR3, TLR4 and Nod1. In this report, we identified the LIM-domain-containing protein TRIP6 as a RIP2-interacting protein in yeast two-hybrid screens. In mammalian cells, TRIP6 interacts with RIP2 in a TNF- or IL-1-dependent manner. Overexpression of TRIP6 potentiates RIP2-mediated NF-κB activation in a dose-dependent manner. The LIM domains of TRIP6 are responsible for its interaction with RIP2. TRIP6 also interacts with TRAF2, a protein that is crucially involved in TNF signaling, as well as the IL-1 receptor, TLR2 and Nod1. Overexpression of TRIP6 potentiates NF-κB activation by TNF, IL-1, TLR2 or Nod1, whereas a dominant negative mutant or RNA-interference construct of TRIP6 inhibits NF-κB activation by TNF, IL-1, TLR2 or Nod1. Moreover, TRIP6 also potentiates RIP2- and Nod1-mediated ERK activation. These data have established a physical and functional association between TRIP6 and RIP2, and suggest that RIP2's involvement in multiple NF-κB and ERK activation pathways is mediated through TRIP6.